Oestrogen receptor–co‐factor–chromatin specificity in the transcriptional regulation of breast cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  EMBO Journal

• Publication date

  2011-11-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/emboj.2011.368PMID 22002538PMCID PMC3243612
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Gene Expression Signature from Human Breast Cancer Cells with Acquired Hormone Independence Identifies MYC as a Mediator of Antiestrogen Resistance

  2011cited by this paper
• microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer.

  2011cited by this paper
• Steroid Receptor Coactivator (SRC) Family: Masters of Systems Biology*

  2010cited by this paper
• Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer.

  2010cited by this paper
• Global characterization of transcriptional impact of the SRC-3 coregulator.

  2010cited by this paper
• Genome-wide assessment of differential roles for p300 and CBP in transcription regulation

  2010cited by this paper
• FOXA1 is a critical determinant of Estrogen Receptor function and endocrine response

  2010cited by this paper
• AIB1 is a predictive factor for tamoxifen response in premenopausal women.

  2010cited by this paper
• Five-Vertebrate ChIP-seq Reveals the Evolutionary Dynamics of Transcription Factor Binding

  2010cited by this paper
• A CTCF-independent role for cohesin in tissue-specific transcription.

  2010cited by this paper
• Genomic Collaboration of Estrogen Receptor α and Extracellular Signal-Regulated Kinase 2 in Regulating Gene and Proliferation Programs

  2010cited by this paper
• An Oestrogen Receptor α-bound Human Chromatin Interactome

  2009cited by this paper
• Perturbation of estrogen receptor alpha localization with synthetic nona-arginine LXXLL-peptide coactivator binding inhibitors.

  2009cited by this paper
• Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family

  2009cited by this paper
• ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions.

  2009cited by this paper
• Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence

  2009cited by this paper
• AIB1 is required for the acquisition of epithelial growth factor receptor-mediated tamoxifen resistance in breast cancer cells.

  2009cited by this paper
• Role of AIB1 for Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells

  2008cited by this paper
• Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen

  2008cited by this paper
• Model-based Analysis of ChIP-Seq (MACS)

  2008influential reference
• Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.

  2007cited by this paper
• Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

  2006cited by this paper
• Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole.

  2006cited by this paper
• CEAS: cis-regulatory element annotation system

  2006cited by this paper
• Genome-wide analysis of estrogen receptor binding sites

  2006cited by this paper
• Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.

  2005cited by this paper
• Selective recruitment of p160 coactivators on glucocorticoid-regulated promoters in Schwann cells.

  2004cited by this paper
• Differential gene regulation by the SRC family of coactivators.

  2004cited by this paper
• Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.

  2004cited by this paper
• Estrogen Receptor-Directs Ordered , Cyclical , and Combinatorial Recruitment of Cofactors on a Natural Target

  2003cited by this paper
• Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.

  2003cited by this paper
• Expression of Sex Steroid Receptors and their Co-Factors in Normal and Malignant Breast Tissue: AIB1 is a Carcinoma-Specific Co-Activator

  2003influential reference
• Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer.

  2003cited by this paper
• Coregulators of estrogen receptor action.

  2002cited by this paper
• Molecular Mechanisms and Cellular Biology of the Steroid Receptor Coactivator (SRC) Family in Steroid Receptor Function

  2002cited by this paper
• Competitive Cofactor Recruitment by Orphan Receptor Hepatocyte Nuclear Factor 4α1: Modulation by the F Domain

  2002cited by this paper
• The human estrogen receptor alpha dimer binds a single SRC-1 coactivator molecule with an affinity dictated by agonist structure.

  2001cited by this paper
• Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer

  2000cited by this paper
• CBP/p300 in cell growth, transformation, and development.

  2000influential reference
• p300 Mediates Functional Synergism between AF-1 and AF-2 of Estrogen Receptor α and β by Interacting Directly with the N-terminal A/B Domains*

  2000cited by this paper
• Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

  2000cited by this paper
• Competition for p300 Regulates Transcription by Estrogen Receptors and Nuclear Factor-&kgr;B in Human Coronary Smooth Muscle Cells

  2000cited by this paper
• Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

  1999cited by this paper
• p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation.

  1998cited by this paper
• The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.

  1998cited by this paper
• AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

  1997cited by this paper
• A signature motif in transcriptional co-activators mediates binding to nuclear receptors

  1997cited by this paper
• A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.

  1996cited by this paper
• p300 is a component of an estrogen receptor coactivator complex.

  1996cited by this paper
• CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription.

  1996cited by this paper
• Progesterone, glucocorticoid and estradiol receptors in MCF-7 cells bind to chromatin.

  1983cited by this paper

• The harmonized activities of HER2–HER3 heterodimer and deacetylated FOXA1 evade hormone response by regulating FOXA1 chromatin binding

  2025cites this paper
• A 3D genome compendium of breast cancer progression

  2025cites this paper
• Transcriptomic Profile of the Trastuzumab-Resistant Breast Cancer Cell Line BT-474

  2025cites this paper
• Comprehensive functional annotation of ESR1-driven enhancers in breast cancer reveals hierarchical activity independent of genomic and epigenomic contexts

  2025cites this paper
• Targeted Inhibition of CBP/p300-NCOA3 Interactions with an α-Methylated Peptide.

  2025cites this paper
• Epigenetic regulation of nuclear receptors: Implications for endocrine-related diseases and therapeutic strategies

  2024cites this paper
• Estrogen-induced chromatin looping changes identify a subset of functional regulatory elements

  2024cites this paper
• Transcription decouples estrogen-dependent changes in enhancer-promoter contact frequencies and spatial proximity

  2023cites this paper
• TRIM25 targets p300 for degradation

  2023cites this paper
• Gene transcription regulation by ER at the single cell and allele level.

  2023cites this paper
• Journal Pre-proof receptor and glucocorticoid receptor work alone and together in cell-type-specific manner: Implications for resilience prediction and targeted therapy

  2022cites this paper
• Mineralocorticoid receptor and glucocorticoid receptor work alone and together in cell-type-specific manner: Implications for resilience prediction and targeted therapy

  2022cites this paper
• Chromatin modifiers - Coordinators of estrogen action.

  2022cites this paper
• Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity

  2022cites this paper
• Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer

  2021influential citation
• Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer

  2021cites this paper
• CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers

  2021influential citation
• An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer

  2021influential citation
• Identification of epigenetic regulators in the estrogen signaling pathway via siRNA screening.

  2021cites this paper
• How Protein Methylation Regulates Steroid Receptor Function

  2021cites this paper
• Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis

  2021cites this paper
• Segregation of nuclear and membrane-initiated actions of estrogen receptor using genetically modified animals and pharmacological tools.

  2021cites this paper
• Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast Cancer

  2020influential citation
• Estradiol-Induced Epigenetically Mediated Mechanisms and Regulation of Gene Expression

  2020cites this paper
• Age-correlated protein and transcript expression in breast cancer and normal breast tissues is dominated by host endocrine effects

  2020cites this paper
• Breast tumors escape endocrine therapy by ER-independent mechanisms triggered by the coordinated activities of HER2/HER3 and deacetylated FOXA1

  2020cites this paper
• Estrogen Receptor on the move: Cistromic plasticity and its implications in breast cancer.

  2020cites this paper
• Epigenetic regulation by estrogen receptor in breast cancer cells

  2019cites this paper
• Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice

  2019cites this paper
• Glucocorticoids regulate cancer cell dormancy

  2019cites this paper
• VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer

  2019influential citation
• Higher order genomic organization and epigenetic control maintain cellular identity and prevent breast cancer

  2019cites this paper
• seq with patient derived co expression networks to identify GRHL 2 as a key co regulator of ERa at enhancers in breast cancer

  2019influential citation
• Relevance of Steroid Biosynthesis, Metabolism and Transport in Pathophysiology and Drug Discovery

  2019cites this paper
• Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression

  2019cites this paper
• Correction for Droog et al., Estrogen receptor α wields treatment-specific enhancers between morphologically similar endometrial tumors

  2018cites this paper
• Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer

  2018cites this paper
• Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer

  2018cites this paper
• Parallel factor ChIP provides essential internal control for quantitative differential ChIP-seq

  2018cites this paper
• Changes in Gene Expression and Estrogen Receptor Cistrome in Mouse Liver Upon Acute E 2 Treatment

  2018cites this paper
• Steroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells

  2018cites this paper
• Techniques for Evaluation of AR Transcriptional Output and Recruitment to DNA.

  2018cites this paper
• A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes

  2018cites this paper
• Dismissal of RNA Polymerase II Underlies a Large Ligand-Induced Enhancer Decommissioning Program.

  2018cites this paper
• CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells.

  2018cites this paper
• Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery

  2018cites this paper
• Corticosteroid Receptors in the Brain: Transcriptional Mechanisms for Specificity and Context-Dependent Effects

  2018cites this paper
• The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2

  2018cites this paper
• Network analysis of ChIP-seq data by VULCAN identifies GRHL2 as a key co-regulator of ERa in luminal breast cancer

  2018influential citation
• CRISPRing the Human Genome for Functional Regulatory Elements

  2018cites this paper
• RNF8 identified as a co-activator of estrogen receptor α promotes cell growth in breast cancer.

  2017cites this paper
• Genetic Investigation of Thyroid Hormone Receptor Function in the Developing and Adult Brain.

  2017cites this paper
• Genetic and Epigenetic Mechanisms in Neural and Hormonal Controls over Female Reproductive Behaviors

  2017cites this paper
• Predicting context specific enhancer-promoter interactions from ChIP-Seq time course data

  2017cites this paper
• UTX promotes hormonally responsive breast carcinogenesis through feed-forward transcription regulation with estrogen receptor

  2017cites this paper
• Emerging functional roles of nuclear receptors in breast cancer.

  2017cites this paper
• Glucocorticoid-induced phosphorylation by CDK9 modulates the coactivator functions of transcriptional cofactor GRIP1 in macrophages

  2017cites this paper
• Estrogen receptor α wields treatment-specific enhancers between morphologically similar endometrial tumors

  2017cites this paper
• Elucidation of the Molecular Mechanisms Underlying Estrogen-Mediated Estrogen Receptor Activation

  2017cites this paper
• Membrane and Nuclear Estrogen Receptor Alpha Actions: From Tissue Specificity to Medical Implications.

  2017cites this paper
• Novel Quantitative ChIP-seq Methods Measure Absolute Fold-Change in ER Binding Upon Fulvestrant Treatment

  2017cites this paper
• Crosstalk of TTC5 cofactor and the estrogen receptor in breast cancer

  2017cites this paper
• Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma

  2016cites this paper
• Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors

  2016cites this paper
• Treatment of Endocrine-Resistant Breast Cancer with a Small Molecule c-Myc Inhibitor

  2016cites this paper
• The Estrogen Receptor α-Cistrome Beyond Breast Cancer.

  2016cites this paper
• Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer

  2016cites this paper
• Molecular basis of stabilization and inhibition of 14-3-3 protein-protein interactions

  2016cites this paper
• Epigenetic Alterations in Endocrine-Dependent Cancers: Implications of Endocrine Dysfunctions

  2016cites this paper
• The first decade of estrogen receptor cistromics in breast cancer.

  2016influential citation
• Changes in Gene Expression and Estrogen Receptor Cistrome in Mouse Liver Upon Acute E2 Treatment.

  2016cites this paper
• Molecular Insights of Pathways Resulting from Two Common PIK3CA Mutations in Breast Cancer.

  2016influential citation
• Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas.

  2016cites this paper
• Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer

  2016cites this paper
• Histone Posttranslational Modifications in Breast Cancer and Their Use in Clinical Diagnosis and Prognosis

  2016cites this paper
• SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast Cancer

  2015influential citation
• Tamoxifen inhibits ERα positive breast cancer progression by disrupting the ERα-JMJD 2 B signaling axis by Rashi Gupta

  2015cites this paper
• WDR5 Expression Is Prognostic of Breast Cancer Outcome

  2015cites this paper
• Inhibition of BET proteins impairs estrogen-mediated growth and transcription in breast cancers by pausing RNA polymerase advancement

  2015cites this paper
• Early programing of uterine tissue by bisphenol A: Critical evaluation of evidence from animal exposure studies.

  2015cites this paper
• Determinants of Receptor- and Tissue-Specific Actions in Androgen Signaling.

  2015cites this paper
• The histone variant H2A.Z is an important regulator of enhancer activity

  2015cites this paper
• Identifying long-range control elements of the BRCA1 promoter

  2015cites this paper
• Low-Cell-Number Epigenome Profiling Aids the Study of Lens Aging and Hematopoiesis

  2015cites this paper
• Cyclin C interacts with steroid receptor coactivator 2 and upregulates cell cycle genes in MCF-7 cells.

  2015cites this paper
• Structure of a biologically active estrogen receptor-coactivator complex on DNA.

  2015cites this paper
• Promestriene Affects GREB 1 Expression in Estrogen Sensitive Breast Cancer Cells

  2015cites this paper
• Oestrogen-dependent regulation of gene expression by cohesin in breast cancer

  2015cites this paper
• Germ-line variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patients

  2015cites this paper
• Paysage épigénétique du cancer du sein

  2014cites this paper
• Complex formation and function of estrogen receptor α in transcription requires RIP140.

  2014influential citation
• ACTIVATION OF ESTROGEN RECEPTOR ALPHA, ARYL HYDROCARBON RECEPTOR, AND NUCLEAR FACTOR ERYTHROID-2 LIKE 2 IN HUMAN BREAST CANCER CELLS

  2014cites this paper
• Transient estrogen receptor binding and p300 redistribution support a squelching mechanism for estradiol-repressed genes.

  2014cites this paper
• Chromatin and epigenetic determinants of estrogen receptor alpha (ESR1) signaling.

  2014cites this paper
• Targeting Nuclear Receptors with Marine Natural Products

  2014cites this paper
• Nuclear receptor modulation--role of coregulators in selective estrogen receptor modulator (SERM) actions.

  2014cites this paper
• Clinical and molecular evaluation of anti-estrogen therapy resistance in breast cancer. Towards tailored use of anti-estrogens and targeted agents

  2014cites this paper
• USP9X downregulation renders breast cancer cells resistant to tamoxifen.

  2014cites this paper
• Chaperonin CCT-Mediated AIB1 Folding Promotes the Growth of ERα-Positive Breast Cancer Cells on Hard Substrates

  2014cites this paper
• Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technology

  2014cites this paper